Journal
/
/
预测使用局部循环单核祖细胞在血管成形术治疗的危肢缺血患者截肢
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
DOI:

07:25 min

September 22, 2020

, , , , , , , , , , , , ,

Chapters

  • 00:04Introduction
  • 01:33Flow-Mediated Dilation (FMD) Evaluation
  • 02:11Lower Limb Vascular Blood Evaluation, Blood Sampling, and Balloon Angioplasty
  • 04:07Circulating Mononuclear Progenitor Cell (MPC) Isolation and Antibody Staining
  • 05:21MPC Quantification
  • 06:10Results: Representative Relationship Between MPC and Hemodynamic Indicators and Lower Limb Amputation Prognosis After Angioplasty
  • 07:04Conclusion

Summary

Automatic Translation

即使严重肢体缺血(CLI)中受阻血管成形术,下肢截肢也可能发生。单核先天细胞(MPC)反映血管修复。本协议描述了从接近血管成形术的循环中量化MPC,以及它与内皮功能障碍和下肢截肢预测的关系。

Related Videos

Read Article